Nucleic acid testing base in Fuzhou(1/10)

Photo shows a staff member works at a nucleic acid testing base at the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022. (Photo: China News Service/Wang Dongming)

The base consists of sample collection cabins, sample processing cabins, sample preserving cabins and high-pressure sterilization cabins with a maximum daily testing capability of 30,000 tubes of 300,000 samples.

A staff member works at a nucleic acid testing base at the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022.

A medical staff scans the information of the nucleic acid samples to the computer at the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022. (Photo: China News Service/Wang Dongming)

A staff member works at a nucleic acid testing base at the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022. (Photo: China News Service/Wang Dongming)

A staff member works at a nucleic acid testing base at the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022. (Photo: China News Service/Wang Dongming)

A staff member works at a nucleic acid testing base at the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022. (Photo: China News Service/Wang Dongming)

Medical staff transfer the nucleic acid samples to the testing laboratory of the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022.

A staff member works at a nucleic acid testing base at the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022.

A staff member works at a nucleic acid testing base at the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022.

A staff member works at a nucleic acid testing base at the Langqi Branch of Fuzhou No. 1 Hospital in southeast China's Fujian Province, March 23, 2022.